Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Magnani

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Cancer Discovery|May 16, 2024
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer EvolutionIros Barozzi, Neil Slaven, Eleonora Canale, et al.
Plos Genetics|January 3, 2023
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, et al.
ACS Nanoscience Au|October 20, 2025
Delivery of Biomolecules into Individual Cells and Subcellular Compartments by Localized Electroporation via NanopipetteFabio Marcuccio, Philip S Goff, Devkee M Vadukul, et al.
Nature Genetics|May 27, 2017
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, et al.
Nature Communications|December 9, 2025
Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbationSabrina Pia Nuccio, Enrico Cadoni, Roxani Nikoloudaki, et al.
Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.
Nature Communications|August 21, 2019
Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancerYlenia Perone, Aaron J Farrugia, Alba Rodríguez-Meira, et al.
Nature Communications|April 23, 2020
Exploiting evolutionary steering to induce collateral drug sensitivity in cancerAhmet Acar, Daniel Nichol, Javier Fernandez-Mateos, et al.
Nature Communications|May 11, 2019
SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancerYlenia Perone, Aaron J Farrugia, Alba Rodríguez-Meira, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbationSabrina Pia Nuccio, Enrico Cadoni, Roxani Nikoloudaki, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Cancer Discovery|May 16, 2024
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer EvolutionIros Barozzi, Neil Slaven, Eleonora Canale, et al.
Plos Genetics|January 3, 2023
ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC)Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, et al.
ACS Nanoscience Au|October 20, 2025
Delivery of Biomolecules into Individual Cells and Subcellular Compartments by Localized Electroporation via NanopipetteFabio Marcuccio, Philip S Goff, Devkee M Vadukul, et al.
Nature Genetics|May 27, 2017
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancerLuca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, et al.
Nature Communications|December 9, 2025
Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbationSabrina Pia Nuccio, Enrico Cadoni, Roxani Nikoloudaki, et al.
Cytokine & Growth Factor Reviews|February 21, 2021
Anticancer innovative therapy congress: Highlights from the 10th anniversary editionFrancesca De Santis, Giovanni Fucà, Dirk Schadendorf, et al.
Nature Communications|August 21, 2019
Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancerYlenia Perone, Aaron J Farrugia, Alba Rodríguez-Meira, et al.
Nature Communications|April 23, 2020
Exploiting evolutionary steering to induce collateral drug sensitivity in cancerAhmet Acar, Daniel Nichol, Javier Fernandez-Mateos, et al.
Nature Communications|May 11, 2019
SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancerYlenia Perone, Aaron J Farrugia, Alba Rodríguez-Meira, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbationSabrina Pia Nuccio, Enrico Cadoni, Roxani Nikoloudaki, et al.
Pageof 13